Clinical Trial Update: Study of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

Study results from a Phase 1/2 trial evaluating the combination of M7824 (bintrafusp alfa) and paclitaxel as second-line therapy in recurrent/metastatic gastric…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• M7824 (bintrafusp alfa) (bintrafusp alfa)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Yonsei University | Conditions: Recurrent/Metastatic Gastric Cancer | Phase 1, Phase 2 | Status: COMPLETED